Live price temporarily unavailable.
Seer (SEER) is a Information Technology company. Latest news and coverage below.
| FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | $656.0K | $6.62M | $15.5M | $16.7M | $14.2M | $16.6M |
| Growth (year over year) | — | +908.7% | +134.1% | +7.5% | −15.0% | +17.0% |
| Gross profit | $656.0K | $3.41M | $7.09M | $8.51M | $7.05M | $8.46M |
| Gross margin | 100.0% | 51.6% | 45.8% | 51.1% | 49.8% | 51.1% |
| Operating income | −$33.6M | −$71.5M | −$97.2M | −$103.5M | −$100.1M | −$78.0M |
| Operating margin | −5129.4% | −1080.1% | −627.6% | −621.0% | −706.4% | −470.5% |
| Net income | −$32.8M | −$71.2M | −$93.0M | −$86.3M | −$86.6M | −$73.6M |
| Net margin | −4996.2% | −1075.5% | −600.1% | −517.8% | −611.1% | −444.0% |
| EPS (diluted) | −$2.48 | −$1.17 | −$1.49 | −$1.35 | — | — |
| Balance sheet | ||||||
| Cash and equivalents | $333.6M | $232.8M | $53.2M | $32.5M | $40.8M | $47.3M |
| Total assets | $442.3M | $539.1M | $487.9M | $436.3M | $366.6M | $296.1M |
| Total liabilities | $10.7M | $36.2M | $40.9M | $39.4M | $39.0M | $36.8M |
| Shareholders' equity | $431.6M | $502.9M | $447.0M | $396.9M | $327.6M | $259.3M |
| Cash flow | ||||||
| Operating cash flow | −$20.8M | −$46.3M | −$60.8M | −$59.1M | −$46.1M | −$44.4M |
| Capital expenditure | $4.53M | $6.92M | $10.3M | $7.31M | $3.58M | $1.80M |
| Free cash flow | −$25.4M | −$53.3M | −$71.0M | −$66.4M | −$49.7M | −$46.2M |
| Share buybacks | $13.0K | $35.0K | $20.0K | $13.0K | $0 | — |
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $4.03M | $4.00M | $4.21M | $4.05M | $4.12M | $4.20M | $2.79M | $3.10M |
| Growth (year over year) | −3.1% | −9.9% | +37.1% | +31.9% | +2.2% | +5.0% | −33.6% | −23.4% |
| Gross profit | $1.94M | $2.02M | $2.06M | $2.11M | $2.11M | $2.18M | $982.0K | $1.51M |
| Gross margin | 48.1% | 50.6% | 49.0% | 52.1% | 51.2% | 52.0% | 35.2% | 48.5% |
| Operating income | −$24.3M | −$23.5M | −$20.7M | −$20.5M | −$19.3M | −$17.4M | −$17.3M | −$16.8M |
| Operating margin | −603.3% | −587.2% | −493.0% | −506.8% | −469.4% | −413.8% | −617.8% | −542.9% |
| Net income | −$21.3M | −$21.7M | −$19.9M | −$19.4M | −$18.2M | −$16.0M | −$16.8M | −$16.9M |
| Net margin | −529.0% | −543.6% | −474.4% | −479.5% | −442.5% | −380.7% | −602.8% | −544.8% |
| EPS (diluted) | −$0.35 | — | — | — | — | — | — | — |
| Balance sheet | ||||||||
| Cash and equivalents | $37.6M | $40.8M | $52.4M | $37.9M | $45.0M | $47.3M | $47.3M | $26.1M |
| Total assets | $383.4M | $366.6M | $347.3M | $322.5M | $308.6M | $296.1M | $272.1M | $256.6M |
| Total liabilities | $38.7M | $39.0M | $36.3M | $34.2M | $36.8M | $36.8M | $30.7M | $31.0M |
| Shareholders' equity | $344.7M | $327.6M | $311.0M | $288.3M | $271.8M | $259.3M | $241.5M | $225.7M |
| Cash flow | ||||||||
| Operating cash flow | −$14.1M | −$11.5M | −$11.4M | −$14.7M | −$7.57M | −$10.8M | −$15.4M | −$9.57M |
| Capital expenditure | $2.19M | −$536.0K | $654.0K | $568.0K | $283.0K | $292.0K | $270.0K | $9.00K |
| Free cash flow | −$16.3M | −$10.9M | −$12.1M | −$15.2M | −$7.85M | −$11.1M | −$15.7M | −$9.58M |
| Share buybacks | −$3.75M | $0 | — | — | — | — | — | — |
From Seer's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
Seer, Inc. is an American biotechnology company headquartered in Redwood City, California. Established in 2017, the company develops technologies for proteomics research.
Source: Wikipedia — Seer, Inc.
No recent news mentioning Seer in our feed yet.